Cell Line Development

Integrating Cell Line and CMC Development

Stephen Hamilton, Ph.D.; Mike Brem

Wheeler Bio

ADCS

Improving the Therapeutic Index of ADCs with a Peptide Linker Technology

Philipp Spycher

Araris Biotech AG

Column: Clinical Trials

CAR-T Study Shines New Spotlight on Clinical Trials Representation

David Alvaro, Ph.D.

Pharma's Almanac

Column: M&A

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Nigel Walker

Nice Insight

Column: New Drug Watch

New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes

David Alvaro, Ph.D.

Pharma's Almanac

Column: Investment

IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?

Danielle Alvarez

Pharma's Almanac

Column: Regulatory Spotlight

The Price of Pain: Acknowledging a Crisis and Encouraging an Alternative

David Alvaro, Ph.D.

Pharma's Almanac

NFTs

Digital Frontiers: What NFTs Can Do for Pharma

Danielle Alvarez

Pharma's Almanac

Column: Supply Chain

Creating a More Resilient Pharmaceutical Supply Chain One Segment at a Time

Tonia Becker

Nice Insight

Mental Health

Mental Health During a Global Pandemic

Marc Technow

Nice Insight

Biotechs

10 More Biotechs Making Moves in 2022

David Alvaro, Ph.D.; Danielle Alvarez

Pharma's Almanac

Cell Therapy

Taking Adoptive Cell Therapies to the Next Level

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Unmet Needs

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Pharma's Almanac

Industry Challenges

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Pharma's Almanac

Quantum Computing

Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management

Cynthia A. Challener, Ph.D.

Pharma's Almanac

API

Small Molecule API Market Trends

James Grote

Nice Insight

Real-World Data

Real-World Data and Artificial Intelligence are Transforming Clinical Development

Jeff Elton, Ph.D.

ConcertAI

Cell and Gene Therapy Analytics

Accelerating the Development of High-Quality Cell and Gene Therapies with Comprehensive, In-house Analytical Support

Hui Chen, Ph.D.

Porton Advanced Solutions

Rare Diseases

Staying Agile to Bring Therapies to Patients with Rare Diseases

Sheila Frame

Amryt Pharma

Immuno-Oncology

Tuning the Myeloid Compartment with a Best-in-Class CDMO

Kiren Khanduga; Alicia Levey, Ph.D.

Pionyr Immunotherapeutics